Insider Trading Activity Genocea Biosciences, Inc. (NASDAQ:GNCA) – CFO Sold 45,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Genocea Biosciences, Inc. (NASDAQ:GNCA)

Jonathan Poole , CFO of Genocea Biosciences, Inc. (NASDAQ:GNCA) reportedly Sold 45,000 shares of the company’s stock at an average price of 6 for a total transaction amount of $270,000.00 SEC Form

Insider Trading History For Genocea Biosciences, Inc. (NASDAQ:GNCA)

  • On 2/10/2014 Stephen J Hoffman, Director, bought 250,931 with an average share price of $12.00 per share and the total transaction amounting to $3,011,172.00.View SEC Filing
  • On 2/10/2014 Polaris Venture Management Co., Major Shareholder, bought 232,820 with an average share price of $12.00 per share and the total transaction amounting to $2,793,840.00.View SEC Filing
  • On 2/10/2014 Plc Glaxosmithkline, Insider, bought 143,773 with an average share price of $12.00 per share and the total transaction amounting to $1,725,276.00.View SEC Filing
  • On 8/12/2014 Polaris Venture Management Co., Major Shareholder, sold 63,794 with an average share price of $13.28 per share and the total transaction amounting to $847,184.32.View SEC Filing
  • On 8/14/2014 Polaris Venture Management Co., Major Shareholder, sold 9,660 with an average share price of $13.01 per share and the total transaction amounting to $125,676.60.View SEC Filing
  • On 8/29/2014 Paul Giannasca, VP, sold 6,760 with an average share price of $12.50 per share and the total transaction amounting to $84,500.00.View SEC Filing
  • On 9/8/2014 Paul Giannasca, VP, sold 2,970 with an average share price of $12.80 per share and the total transaction amounting to $38,016.00.View SEC Filing

    • Analyst Ratings For Genocea Biosciences, Inc. (NASDAQ:GNCA)
    These are 4 Buy Ratings .
    The current consensus rating for Genocea Biosciences, Inc. (NASDAQ:GNCA) is Buy (Score: 3.00) with a consensus target price of $21.00 , a potential (260.21% upside)

    Analyst Ratings History For Genocea Biosciences, Inc. (NASDAQ:GNCA)

    • On 4/1/2016 Stifel Nicolaus Boost Price Target of rating Buy with a price target of $11.00 to $13.00
    • On 9/29/2016 Piper Jaffray Companies Lower Price Target of rating Overweight with a price target of $9.00 to $12.00
    • On 12/14/2016 Cowen and Company Set Price Target of rating Buy with a price target of $40.00
    • On 1/23/2017 FBR & Co Reiterated Rating Outperform
    • On 7/24/2017 Needham & Company LLC Upgraded rating Hold to Buy

    Recent Trading Activity for Genocea Biosciences, Inc. (NASDAQ:GNCA)
    Shares of Genocea Biosciences, Inc. closed the previous trading session at 5.83 up +0.78 15.45% with 8,173,823 shares trading hands.